Viewing Study NCT00838656


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2025-12-25 @ 9:00 PM
Study NCT ID: NCT00838656
Status: UNKNOWN
Last Update Posted: 2013-09-17
First Post: 2009-02-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sponsor: Warwick Medical School
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module